Next Article in Journal
Metronomic Temozolomide (mTMZ) and Bevacizumab—The Safe and Effective Frontier for Treating Metastatic Neuroendocrine Tumors (NETs): A Single-Center Experience
Previous Article in Journal
Risk Factors for Radiation Necrosis and Local Recurrence after Proton Beam Therapy for Skull Base Chordoma or Chondrosarcoma
 
 
Article

Article Versions Notes

Cancers 2023, 15(23), 5686; https://doi.org/10.3390/cancers15235686
Action Date Notes Link
article xml file uploaded 1 December 2023 15:16 CET Original file -
article xml uploaded. 1 December 2023 15:16 CET Update https://www.mdpi.com/2072-6694/15/23/5686/xml
article pdf uploaded. 1 December 2023 15:16 CET Version of Record https://www.mdpi.com/2072-6694/15/23/5686/pdf
article supplementary file uploaded. 1 December 2023 15:16 CET - https://www.mdpi.com/2072-6694/15/23/5686#supplementary
article html file updated 1 December 2023 15:19 CET Original file https://www.mdpi.com/2072-6694/15/23/5686/html
Back to TopTop